Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Replimune Stock Is Soaring Today

TheMotleyFool

0 0

Shares of Replimune Group (NASDAQ: REPL) were soaring 13.3% higher as of 11:01 a.m. EDT on Thursday after rising as much as 22.4% earlier in the day. The big jump resulted from the company's announcement that it will present encouraging data from two early-stage clinical studies evaluating experimental immunotherapies RP1 and RP2 at the Society for Immunotherapy of Cancer (SITC) annual meeting in November.

Positive clinical news is exactly what a clinical-stage biotech stock like Replimune needs to get investors excited. The company's scheduled virtual poster presentations at SITC are indeed good news.

Image source: Getty Images.

Source Fool.com

Like: 0

REPL

Share